394 related articles for article (PubMed ID: 10442570)
1. Growth hormone and the metabolic syndrome.
Johannsson G; Bengtsson BA
J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570
[TBL] [Abstract][Full Text] [Related]
2. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control.
Ahn CW; Kim CS; Nam JH; Kim HJ; Nam JS; Park JS; Kang ES; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
Clin Endocrinol (Oxf); 2006 Apr; 64(4):444-9. PubMed ID: 16584518
[TBL] [Abstract][Full Text] [Related]
3. Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy.
Attallah H; Friedlander AL; Hoffman AR
Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S62-7. PubMed ID: 16624603
[TBL] [Abstract][Full Text] [Related]
4. [Abdominal obesity and coronary heart disease. Pathophysiology and clinical significance].
Hauner H
Herz; 1995 Feb; 20(1):47-55. PubMed ID: 7713476
[TBL] [Abstract][Full Text] [Related]
5. Evidence for distinct effects of GH and IGF-I in the metabolic syndrome.
Maison P; Balkau B; Souberbielle JC; Cunin P; Vol S; Macquin-Mavier I; Eschwège E;
Diabet Med; 2007 Sep; 24(9):1012-8. PubMed ID: 17535291
[TBL] [Abstract][Full Text] [Related]
6. The origins and consequences of obesity. Diabetes.
Björntorp P
Ciba Found Symp; 1996; 201():68-80; discussion 80-9, 188-93. PubMed ID: 9017275
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
9. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.
Smith SR; Lovejoy JC; Greenway F; Ryan D; deJonge L; de la Bretonne J; Volafova J; Bray GA
Metabolism; 2001 Apr; 50(4):425-35. PubMed ID: 11288037
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
11. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure.
Johannsson G; Mårin P; Lönn L; Ottosson M; Stenlöf K; Björntorp P; Sjöström L; Bengtsson BA
J Clin Endocrinol Metab; 1997 Mar; 82(3):727-34. PubMed ID: 9062473
[TBL] [Abstract][Full Text] [Related]
13. Relationships of insulin sensitivity with fatness and fitness and in older men and women.
Ouyang P; Sung J; Kelemen MD; Hees PS; DeRegis JR; Turner KL; Bacher AC; Stewart KJ
J Womens Health (Larchmt); 2004 Mar; 13(2):177-85. PubMed ID: 15072732
[TBL] [Abstract][Full Text] [Related]
14. The regulation of adipose tissue distribution in humans.
Björntorp P
Int J Obes Relat Metab Disord; 1996 Apr; 20(4):291-302. PubMed ID: 8680455
[TBL] [Abstract][Full Text] [Related]
15. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
[TBL] [Abstract][Full Text] [Related]
16. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
[TBL] [Abstract][Full Text] [Related]
18. Melancholic depression and abdominal fat distribution: a mini-review.
Mann JN; Thakore JH
Stress; 1999 Aug; 3(1):1-15. PubMed ID: 19016189
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
Yuen KC; Dunger DB
Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
[TBL] [Abstract][Full Text] [Related]
20. [Non-pharmacological therapy of metabolic syndrome].
Wirth A
Herz; 1995 Feb; 20(1):56-69. PubMed ID: 7713478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
